Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McKesson Tagged With Rare Class I Recall For Clinical Decision Support Software

This article was originally published in The Pink Sheet Daily

Executive Summary

McKesson Corp.’s McKesson Anesthesia Care clinical decision support system was the subject of a class I recall, a rarity in the health information technology sector that could offer insights into FDA oversight of the space going forward.

You may also be interested in...



Digital Health Regulation Debate Continues At mHealth Summit

Federal officials took pains at this year’s mHealth Summit in Washington, D.C., to describe their excitement for the digital health field and their plans to minimize the “touch” of federal regulation. But it was also clear at the meeting that a significant component of the health information technology space still looks skeptically at FDA and its long-term intentions.

Pill-Based Obesity Device From Gelesis Gets Financing

Startup Gelesis Inc. announced a $12 million funding round to support an FDA study for its Gelesis 100 “smart pill” as a tool to induce feelings of hunger and satiety.

Big Tech Firms Target Health Care Space With Cheap Sensors In Smartphones

Recent activities by three smartphone giants point to a potential future where the phone itself more frequently serves as a monitoring or diagnosing device, in place of external sensors. If the trend rolls on, it could have important implications for the mobile health sector.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS076994

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel